Pfizer, BioNTech say COVID-19 booster highly effective
Reuters, 22 Oct 2021
Pfizer and BioNTech said a booster shot of their COVID-19 vaccine restored efficacy to 95.6% against the virus, including the Delta variant, according to data from a Phase III trial.
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en